Are You Living with Pain from Advanced-stage Cancer?
See if you could be eligible to participate in a study to reduce cancer-related pain by taking a short survey on our website.
Copyright © 2020.
Tetra Bio-Pharma
All rights reserved.
See if you could be eligible to participate in a study to reduce cancer-related pain by taking a short survey on our website.
This study was developed by Tetra Bio-Pharma with the help of experts of cannabinoids. The study aims to reduce cancer-related pain and improve quality of life for adults with advanced cancer by verifying the effectiveness of an investigational drug which is vaporized pharmaceutical grade cannabis (PPP001).
Tetra Bio-Pharma is a global leader in cannabinoid-derived drug discovery and development. We focus on the therapeutic areas of pain and oncology backed by scientific validation and safety data.
This study will be conducted according to the Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA) requirements.
Results from the Plentitude Study may help to advance the standard of care for patients with advanced cancer, potentially providing avenues for new research and treatment, as well as providing clear, scientifically sound data on the efficacy of investigational pharmaceutical grade cannabis for cancer.